Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.

Translated title of the contribution: Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.

N.W.C.J. van de Donk, N Kroger, U. Hegenbart, P. Corradini, J.F. San Miguel, H. Goldschmidt, J.A. Perez-Simon, M. Zijlmans, R.A. Raymakers, V. Montefusco, F.A. Ayuk, M.H.J. van Oers, A. Nagler, L.F. Verdonck, H.M. Lokhorst

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionRemarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Original languageUndefined/Unknown
Pages (from-to)3415-3416
Number of pages2
JournalBlood
Volume107
Issue number8
Publication statusPublished - 2006

Cite this